Abstract
ObjectivePatients with differentiated thyroid carcinoma (DTC) have generally an encouraging prognosis, however, some patients develop an increasing level of serum thyroglobulin (Tg) without detection of a recurrent tumor using conventional imaging tools such as the iodine-131 whole-body scanning (I131 scan). The objective of our study was to evaluate the clinical significance of [F18]-FDG-PET/CT in detection of tumor recurrence or metastases, in comparison to conventional imaging such as the I131 scan. Patients and methodsBetween January 2013 and June 2013, [18F]-FDG-PET/CT examination was done for 12 DTC patients with elevated thyroglobulin levels and who did not show any pathological lesions when conventional imaging modalities were used. All involved patients had undergone total thyroidectomy, and who had been followed-up by whole body iodine scan [F18]-FDG PET/CT data were evaluated for detecting recurrent DTC lesions in study patients and compared with those of other radiological and/or cytological investigations. ResultsFive of 12 patients (41.6 %) showed pathological [F18]-FDG uptake in the absence of abnormal uptake in whole body iodine scan. Conclusion[F18]-FDG-PET/CT affords a valuable diagnostic method in detection of recurrence or metastasis in patients with DTC who are tumor-free on conventional imaging studies with high Tg levels.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: The Egyptian Journal of Radiology and Nuclear Medicine
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
